Jazz Pharmaceuticals plc Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 5 | $4.04 | $4.30 | $4.18 |
Q2 2024 | 6 | $4.75 | $5.07 | $4.92 |
Q3 2024 | 14 | $4.96 | $5.97 | $5.52 |
Q4 2024 | 6 | $5.85 | $6.23 | $6.05 |
Q1 2025 | 7 | $4.19 | $4.47 | $4.34 |
Q2 2025 | 7 | $5.01 | $5.34 | $5.18 |
Q3 2025 | 13 | $5.50 | $5.87 | $5.70 |
Q4 2025 | 7 | $5.72 | $6.09 | $5.92 |
Jazz Pharmaceuticals plc Earnings Date And Information
Jazz Pharmaceuticals plc last posted its earnings results on Wednesday, July 31st, 2024. The company reported $5.3 earnings per share for the quarter, topping analysts' consensus estimates of $4.68 by $0.62. The company had revenue of 1.02 B for the quarter and had revenue of 3.83 B for the year. Jazz Pharmaceuticals plc has generated $7 earnings per share over the last year ($6.1 diluted earnings per share) and currently has a price-to-earnings ratio of 17.66. Jazz Pharmaceuticals plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Jazz Pharmaceuticals plc Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/01/2024 | Q2 2024 | $2.68 | $1.01 B | $1.02 B | ||
05/02/2024 | Q1 2024 | -$0.23 | $901.98 M | |||
04/26/2024 | Q4 2023 | $1.50 | $1.01 B | |||
11/08/2023 | Q3 2023 | $4.90 | $2.33 | -2.57 | $968.41 M | $972.14 M |
08/09/2023 | Q2 2023 | $4.46 | $1.63 | -2.83 | $941.99 M | $957.32 M |
05/10/2023 | Q1 2023 | $4.26 | $1.09 | -3.17 | $892.81 M | |
05/01/2023 | Q4 2022 | -$3.81 | $972.12 M | |||
11/09/2022 | Q3 2022 | $4.72 | -$0.27 | -4.99 | $939.98 M | $940.65 M |
08/03/2022 | Q2 2022 | $4.20 | $0.56 | -3.64 | $932.88 M | |
05/04/2022 | Q1 2022 | $3.75 | $0.09 | -3.66 | $852.45 M | $813.72 M |
03/01/2022 | Q4 2021 | $3.71 | -$0.57 | -4.28 | $864.30 M | $896.73 M |
11/09/2021 | Q3 2021 | $3.27 | -$0.86 | -4.13 | $832.01 M | $838.12 M |
08/03/2021 | Q2 2021 | $3.55 | -$6.11 | -9.66 | $731.89 M | $751.81 M |
05/04/2021 | Q1 2021 | $3.69 | $2.16 | -1.53 | $609.32 M | $607.58 M |
02/23/2021 | Q4 2020 | $4.10 | $2.39 | -1.71 | $638.84 M | $665.52 M |
11/02/2020 | Q3 2020 | $4.03 | $2.67 | -1.36 | $577.62 M | $600.89 M |
08/04/2020 | Q2 2020 | $3.38 | $2.07 | -1.31 | $503.21 M | $562.44 M |
05/05/2020 | Q1 2020 | $0.66 | -$2.82 | -3.48 | $544.56 M | $534.73 M |
02/25/2020 | Q4 2019 | $4.16 | $1.31 | -2.85 | $560.55 M | $581.74 M |
11/05/2019 | Q3 2019 | $3.59 | $1.80 | -1.79 | $523.89 M | $537.70 M |
Jazz Pharmaceuticals plc Earnings: Frequently Asked Questions
-
When is Jazz Pharmaceuticals plc's earnings date?
Jazz Pharmaceuticals plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
Did Jazz Pharmaceuticals plc beat their earnings estimates last quarter?
In the previous quarter, Jazz Pharmaceuticals plc (:JAZZ) reported $5.3 earnings per share (EPS) to beat the analysts' consensus estimate of $4.68 by $0.62.
-
How can I listen to Jazz Pharmaceuticals plc's earnings conference call?
The conference call for Jazz Pharmaceuticals plc's latest earnings report can be listened to online.
-
How can I read Jazz Pharmaceuticals plc's conference call transcript?
The conference call transcript for Jazz Pharmaceuticals plc's latest earnings report can be read online.
-
How much revenue does Jazz Pharmaceuticals plc generate each year?
Jazz Pharmaceuticals plc (:JAZZ) has a recorded annual revenue of $3.83 B.
-
How much profit does Jazz Pharmaceuticals plc generate each year?
Jazz Pharmaceuticals plc (:JAZZ) has a recorded net income of $3.83 B. Jazz Pharmaceuticals plc has generated $6.55 earnings per share over the last four quarters.
-
What is Jazz Pharmaceuticals plc's price-to-earnings ratio?
Jazz Pharmaceuticals plc (:JAZZ) has a price-to-earnings ratio of 17.66 and price/earnings-to-growth ratio is 1.12.